379 related articles for article (PubMed ID: 27084913)
21. Discordance and accordance between patient's and physician's assessments in rheumatoid arthritis.
Furu M; Hashimoto M; Ito H; Fujii T; Terao C; Yamakawa N; Yoshitomi H; Ogino H; Ishikawa M; Matsuda S; Mimori T
Scand J Rheumatol; 2014; 43(4):291-5. PubMed ID: 24650255
[TBL] [Abstract][Full Text] [Related]
22. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
23. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
[TBL] [Abstract][Full Text] [Related]
24. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
[TBL] [Abstract][Full Text] [Related]
25. Association of cumulative anti-cyclic citrullinated protein antibodies with radiographic progression in patients with rheumatoid arthritis.
Joo YB; Park YJ; Park KS; Kim KJ
Clin Rheumatol; 2019 Sep; 38(9):2423-2432. PubMed ID: 31049760
[TBL] [Abstract][Full Text] [Related]
26. One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcome and its prognostic factors between maintained remissions with patient-reported outcome index and physician-oriented disease activity indices.
Katayama K; Okubo T; Sato T; Kamiya K; Fukai R; Abe S; Ito H; Makino Y; Kamishima T
Mod Rheumatol; 2016 Nov; 26(6):817-827. PubMed ID: 26915909
[TBL] [Abstract][Full Text] [Related]
27. Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis: Results of a cohort study.
Santos-Moreno P; Sánchez G; Castro C
Medicine (Baltimore); 2019 Feb; 98(5):e14181. PubMed ID: 30702571
[TBL] [Abstract][Full Text] [Related]
28. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
29. Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry.
Bergstra SA; Couto MC; Govind N; Chopra A; Salomon Escoto K; Murphy E; Huizinga TW; Allaart CF
RMD Open; 2019; 5(2):e000969. PubMed ID: 31413867
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
31. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
Choi S; Lee KH
PLoS One; 2018; 13(4):e0195550. PubMed ID: 29624625
[TBL] [Abstract][Full Text] [Related]
32. Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria.
Shahouri SH; Michaud K; Mikuls TR; Caplan L; Shaver TS; Anderson JD; Weidensaul DN; Busch RE; Wang S; Wolfe F
Arthritis Rheum; 2011 Nov; 63(11):3204-15. PubMed ID: 21739423
[TBL] [Abstract][Full Text] [Related]
33. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative.
de Punder YM; Hendrikx J; den Broeder AA; Valls Pascual E; van Riel PL; Fransen J
J Rheumatol; 2013 Aug; 40(8):1268-74. PubMed ID: 23729803
[TBL] [Abstract][Full Text] [Related]
34. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
[TBL] [Abstract][Full Text] [Related]
35. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
[TBL] [Abstract][Full Text] [Related]
36. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
Lee YC; Cui J; Lu B; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME; Solomon DH
Arthritis Res Ther; 2011 Jun; 13(3):R83. PubMed ID: 21651807
[TBL] [Abstract][Full Text] [Related]
37. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
Pincus T; Furer V; Keystone E; Yazici Y; Bergman MJ; Luijtens K
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
[TBL] [Abstract][Full Text] [Related]
38. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
[TBL] [Abstract][Full Text] [Related]
40. Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
Perrotta FM; De Socio A; Scriffignano S; Lubrano E
Clin Rheumatol; 2018 Jun; 37(6):1449-1455. PubMed ID: 29468339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
